麻醉交接与肿瘤细胞减灭术联合腹腔热灌注化疗围术期及短期结局的关联
单中心回顾性研究纳入2017至2022年182例接受肿瘤细胞减灭术联合腹腔热灌注化疗的患者,按麻醉主治医师和非主治医师交接次数分组。调整混杂因素后,主治医师交接次数与30天严重并发症及住院时长无差异,但非主治医师交接≥2次与更长的总住院和ICU住院时间相关。
要点
- 主治医师交接次数(0-1次 vs ≥2次)与30天严重并发症、ICU及总住院时间无显著差异。
核心结论
- 多次麻醉交接未增加肿瘤细胞减灭术联合腹腔热灌注化疗患者30天严重并发症风险。
- 非主治医师交接≥2次与更长的总住院和ICU住院时间相关。
研究设计与样本
- 单中心回顾性研究,纳入2017至2022年接受肿瘤细胞减灭术联合腹腔热灌注化疗的182例患者。
- 按麻醉主治医师和非主治医师交接次数(0-1次或≥2次)分层,采用logistic和负二项回归模型调整患者及病例复杂度相关协变量。
主要发现
- 中位手术时间720分钟(四分位距540-900分钟)。
- 主治医师交接≥2次者35例(19%),0-1次者147例(81%);非主治医师交接≥2次者53例(29%),0-1次者120例(71%)。
- 调整模型中,主治医师交接组间30天严重并发症、ICU及总住院时间无差异。
临床怎么用
- 在肿瘤细胞减灭术联合腹腔热灌注化疗这类长时间手术中,非主治医师多次交接可能提示需关注住院时间延长风险。
局限性
- 单中心回顾性设计,样本量182例,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anesthesiologists transition patient care to combat clinician fatigue and accommodate shift limitations. Studies exploring the association of increased handovers with patient outcomes have conflicting findings. Here, we investigate the association of anesthesia handovers with perioperative outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. METHODS: Patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution from 2017 to 2022 were stratified by the number of anesthesia attending and nonattending (nurse anesthetist/resident) handovers (0-1 or ≥2). Primary outcomes were intensive care unit and hospital length of stay, in addition to 30-day serious morbidity. Logistic and negative binomial regression models were adjusted for covariates related to patient and case complexity. RESULTS: A total of 182 patients were included. Median operative time was 720 minutes (interquartile range, 540-900 minutes). Most cases had fewer than 2 attending handovers (n = 147, 81% vs ≥2 handovers n = 35, 19%) and 2 nonattending handovers (n = 120, 71% vs ≥2 handovers n = 53, 29%). In adjusted models, there were no differences in 30-day serious morbidity and intensive care unit or hospital length of stay between the attending handover groups (0-1 vs ≥2). Patients with ≥2 non-attending handovers had similar odds of 30-day serious morbidity compared with the 0-1 group (odds ratio, 1.613, 95% confidence interval, 0.733-3.550, P = .235), but a longer total hospital (incidence rate ratio, 1.301, 95% confidence interval, 1.071-1.579, P = .008) and intensive care unit length of stay (incidence rate ratio 1.548, 95% confidence interval, 1.038-2.049, P = .030). CONCLUSIONS: Multiple anesthesia handovers were not associated with an increased risk of serious morbidity for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. However, increased handovers (≥2) between nonattending providers was associated with longer hospital and intensive care unit length of stays.
引用
- Radomski SN, Kajstura T, Florissi IS, et al. Association of anesthesia handovers with perioperative and short-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surgery. 2024. PMID: 39191603. doi:10.1016/j.surg.2024.07.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。